Incidence of tardive dyskinesia in first and second generation antipsychotic medications

被引:0
|
作者
Tapp, A. [1 ]
Wood, A. E. [1 ]
Kennedy, A. [1 ]
机构
[1] VA Puget Sound Hlth Care Syst, Tacoma, WA USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:507 / 507
页数:1
相关论文
共 50 条
  • [41] Miscellaneous treatments for antipsychotic-induced tardive dyskinesia
    Soares-Weiser, Karla
    Rathbone, John
    Ogawa, Yusuke
    Shinohara, Kiyomi
    Bergman, Hanna
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (03):
  • [42] Reply to "Dosing equivalency of second-generation antipsychotic medications"
    Davis, JM
    Chen, N
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 502 - 503
  • [43] PERSISTENT HYPERGLYCEMIA SECONDARY TO SECOND-GENERATION ANTIPSYCHOTIC MEDICATIONS
    Arrese, N. Soulages
    Middleman, A. B.
    Meyer, J. D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 382 - 383
  • [44] The WPA consensus on the use and usefulness of the second generation antipsychotic medications
    Sartorius, N
    EUROPEAN PSYCHIATRY, 2004, 19 : 60S - 61S
  • [45] Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia
    Kuo, Chian-Jue
    Yang, Shu-Yu
    Liao, Ya-Tang
    Chen, Wei J.
    Lee, Wen-Chung
    Shau, Wen-Yi
    Chang, Yao-Tung
    Tsai, Shang-Ying
    Chen, Chiao-Chicy
    SCHIZOPHRENIA BULLETIN, 2013, 39 (03) : 648 - 657
  • [46] FDA-Approved Medications to Treat Tardive Dyskinesia
    McEvoy, Joseph P.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (01)
  • [47] Significant dyskinesia risk in children treated with second generation antipsychotic drugs
    Thaker, GK
    Wonodi, I
    Reeves, G
    Hong, LE
    Adami, H
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 195S - 195S
  • [48] Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia
    El-Sayeh, Hany G.
    Rathbone, John
    Soares-Weiser, Karla
    Bergman, Hanna
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [49] An international comparison of the profiles of forensic psychiatric patients given first and second-generation antipsychotic medications
    Eronen, M
    EUROPEAN PSYCHIATRY, 2002, 17 : 26S - 26S
  • [50] Cognitive change after treatment with second generation antipsychotic medications in first episode schizophrenia: Is it a practice effect?
    Goldberg, Terry E.
    Goldman, Robert
    Burdick, Katherine
    Malhotra, Anil K.
    Lencz, Todd
    Kane, John
    Robinson, Delbert
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S252 - S253